For Immediate Release
Tanner Pharma Group
CHARLOTTE, N.C., December 1, 2015 – Tanner Pharma Group is pleased to announce the hiring of Jonathan Bracey as Managing Director – UK, effective 1 December, 2015.
Mr. Bracey brings two decades of management experience, making him an optimal candidate in leading the recently established UK/EU operations based in London. Prior to joining Tanner Pharma Group, Mr. Bracey led various operations in Big Pharma, Specialty Pharma, Generics and most recently consultancy within the pharmaceutical industry. Within these organizations, he worked in general management, operations, sales, procurement, and supply chain roles with UK, EU, MENA, and Global reach. Mr. Bracey also served in HMS as a logistics officer.
“Jonathan’s breadth of experience in leadership, operations, pharmaceuticals and business development make him an ideal Managing Director for our new UK office,” stated Banks Bourne, Founder of Chairman of Tanner Pharma Group and CEO of Bourne Partners, the parent company of Tanner Pharma Group.
The newly established UK office provides access to critical European markets where Tanner Pharma Group expects large growth in the areas of Clinical Trial Supply and Global Access Programmes. A presence in the UK provides customer access, sourcing opportunities as well as a deep pool of human capital. Mr. Bracey’s responsibilities will be to capitalize on this growth opportunity and scale Tanner Pharma Group in the UK and Europe.
About Tanner Pharma Group
For over 15 years, Tanner Pharma Group has provided highly specialized pharmaceutical services to its partners around the world. Leading pharmaceutical and biotech companies partner with Tanner Pharma to license and commercialize their products in challenging international markets, develop and manage their Global Access Programmes and source comparator drugs for clinical trials and bioanalysis. By partnering with Tanner Pharma, manufacturers are able to focus on their primary markets and strategies while ensuring that the services they need will follow a strictly controlled protocol of quality.
Headquartered in Charlotte, N.C., USA, with offices in London, São Paulo and Mexico City, Tanner Pharma Group’s reach extends to Europe, Asia, the Middle East, Australia, Canada and Latin America.
For more information about Tanner Pharma Group, please visit TannerPharma.com.
About Tanner Pharma Group
For over 15 years, Tanner’s executive team has provided specialty distribution of pharmaceuticals from markets of availability to markets of need. When healthcare providers in international markets require treatments not currently available in their home market, they rely on Tanner to source and deliver the product from its global network of pharmaceutical manufacturers. Based on its track record of accountability and experience managing regulatory-compliant access programs, top pharmaceutical and biotech companies partner with Tanner to develop and manage their global access programs. By partnering with Tanner, pharma and biotech companies are able to focus on their primary markets while ensuring that patients in international markets of need are receiving their products through a strictly controlled channel.
Tanner’s International Access Division serves providers in 24 of the most challenging countries by developing, implementing and managing global access programs including Named Patient Programs, Expanded Access Programs, Compassionate Use Programs, Government & Private Provider Tender fulfillment and Emergency Supply allocations. Tanner’s Clinical Trials Division procures comparator products for manufacturers, CRO’s and research centers from a broad range of sources. Additionally, the company is able to provide clinical trial logistics and inventory management for trials conducted in the U.S., Europe, Mexico and Brazil.
Headquartered in the U.S., Tanner’s reach includes Europe, Northeast Asia, Southeast Asia, the Middle East, Australia, Canada and Latin America, including Brazil, Mexico, the Caribbean, Central America and all of South America.
For more information about Tanner Pharma Group, please visit www.tannerpharma.com.
For more information about Merz or the Company’s products, please visit www.merzusa.com.